Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Design Therapeutics (DSGN) Leases (2021 - 2026)

Design Therapeutics' Leases history spans 1 years, with the latest figure at $3.6 million for Q4 2021.

  • On a quarterly basis, Leases changed N/A to $3.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was $3.6 million, a N/A change, with the full-year FY2021 number at $3.6 million, changed N/A from a year prior.
  • Leases hit $3.6 million in Q4 2021 for Design Therapeutics, down from $3.7 million in the prior quarter.
  • Over the last five years, Leases for DSGN hit a ceiling of $3.7 million in Q3 2021 and a floor of $3.6 million in Q4 2021.